181 related articles for article (PubMed ID: 33648748)
1. Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 study.
Prieske K; Woelber L; Muallem MZ; Eulenburg C; Jueckstock JK; Hilpert F; de Gregorio N; Iborra S; Ignatov A; Hillemanns P; Fuerst S; Strauss HG; Baumann K; Beckmann M; Mustea A; Meier W; Harter P; Wimberger P; Sehouli J; Mahner S
Gynecol Oncol; 2021 May; 161(2):442-448. PubMed ID: 33648748
[TBL] [Abstract][Full Text] [Related]
2. Primary treatment and relative survival by stage and age in vulvar squamous cell carcinoma: A population-based SweGCG study.
Hellman K; Holmberg E; Bjurberg M; Borgfeldt C; Dahm-Kähler P; Flöter Rådestad A; Hjerpe E; Högberg T; Marcickiewicz J; Rosenberg P; Stålberg K; Tholander B; Kjølhede P; Åvall-Lundqvist E
Gynecol Oncol; 2020 Dec; 159(3):663-671. PubMed ID: 32988623
[TBL] [Abstract][Full Text] [Related]
3. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.
Sznurkowski JJ; Żawrocki A; Biernat W
BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant radiotherapy and local recurrence in vulvar cancer - a subset analysis of the AGO-CaRE-1 study.
Woelber L; Prieske K; Eulenburg CZ; Corradini S; Petersen C; Bommert M; Blankenstein T; Hilpert F; de Gregorio N; Iborra S; Sehouli J; Ignatov A; Hillemanns P; Fuerst S; Strauss HG; Baumann K; Beckmann MW; Mustea A; Mahner S; Jaeger A
Gynecol Oncol; 2022 Jan; 164(1):68-75. PubMed ID: 34794839
[TBL] [Abstract][Full Text] [Related]
5. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
Kortekaas KE; Bastiaannet E; van Doorn HC; de Vos van Steenwijk PJ; Ewing-Graham PC; Creutzberg CL; Akdeniz K; Nooij LS; van der Burg SH; Bosse T; van Poelgeest MIE
Gynecol Oncol; 2020 Dec; 159(3):649-656. PubMed ID: 32972785
[TBL] [Abstract][Full Text] [Related]
6. Vulvar cancer: surgical management and survival trends in a low resource setting.
Kumar N; Ray MD; Sharma DN; Pandey R; Lata K; Mishra A; Wankhede D; Saikia J
J Egypt Natl Canc Inst; 2020 Jan; 32(1):4. PubMed ID: 32372283
[TBL] [Abstract][Full Text] [Related]
7. Perineural Invasion Is an Independent Pathologic Indicator of Recurrence in Vulvar Squamous Cell Carcinoma.
Holthoff ER; Jeffus SK; Gehlot A; Stone R; Erickson SW; Kelly T; Quick CM; Post SR
Am J Surg Pathol; 2015 Aug; 39(8):1070-4. PubMed ID: 25786085
[TBL] [Abstract][Full Text] [Related]
8. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group.
Woelber L; Prieske K; Eulenburg C; Oliveira-Ferrer L; de Gregorio N; Klapdor R; Kalder M; Braicu I; Fuerst S; Klar M; Strauss HG; Beckmann M; Meier W; Ignatov A; Mustea A; Jueckstock J; Schmidt G; Bauerschlag D; Hellriegel M; Canzler U; Petry KU; Kommoss S; Hantschmann P; Heubner M; Mahner S; Burandt E
Am J Obstet Gynecol; 2021 Jun; 224(6):595.e1-595.e11. PubMed ID: 33453182
[TBL] [Abstract][Full Text] [Related]
9. Inguino-femoral radiotherapy in vulvar squamous cell carcinoma: clues to revised indications in patients with only one intracapsular lymph node metastasis.
Serre E; Raimond E; Diguisto C; Bendifallah S; Body G; Touboul C; Graesslin O; Carcopino X; Daraï E; Ouldamer L;
Acta Oncol; 2020 May; 59(5):518-524. PubMed ID: 31718368
[No Abstract] [Full Text] [Related]
10. HPV status and favourable outcome in vulvar squamous cancer.
Wakeham K; Kavanagh K; Cuschieri K; Millan D; Pollock KG; Bell S; Burton K; Reed NS; Graham SV
Int J Cancer; 2017 Mar; 140(5):1134-1146. PubMed ID: 27864932
[TBL] [Abstract][Full Text] [Related]
11. Trends in HPV-dependent and HPV-independent vulvar cancers: The changing face of vulvar squamous cell carcinoma.
Eva LJ; Sadler L; Fong KL; Sahota S; Jones RW; Bigby SM
Gynecol Oncol; 2020 May; 157(2):450-455. PubMed ID: 32037194
[TBL] [Abstract][Full Text] [Related]
12. Predicting the course of disease in recurrent vulvar cancer - A subset analysis of the AGO-CaRE-1 study.
Woelber L; Eulenburg C; Kosse J; Neuser P; Heiss C; Hantschmann P; Mallmann P; Tanner B; Pfisterer J; Jückstock J; Hilpert F; de Gregorio N; Iborra S; Sehouli J; Ignatov A; Hillemanns P; Fürst S; Strauss HG; Mahner S; Prieske K;
Gynecol Oncol; 2019 Sep; 154(3):571-576. PubMed ID: 31324454
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers p16, Human Papillomavirus and p53 Predict Recurrence and Survival in Early Stage Squamous Cell Carcinoma of the Vulva.
Hay CM; Lachance JA; Lucas FL; Smith KA; Jones MA
J Low Genit Tract Dis; 2016 Jul; 20(3):252-6. PubMed ID: 26855143
[TBL] [Abstract][Full Text] [Related]
14. Multivariate analysis of prognostic factors in primary squamous cell vulvar cancer: The role of perineural invasion in recurrence and survival.
Ferrari F; Forte S; Ardighieri L; Bonetti E; Fernando B; Sartori E; Odicino F
Eur J Surg Oncol; 2019 Nov; 45(11):2115-2119. PubMed ID: 31378417
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of AJCC and an Alternative Tumor Classification System for Primary Vulvar Squamous Cell Carcinoma.
Le ST; Karia PS; Vollenhoven BJ; Besaw RJ; Feltmate CM; Schmults CD
J Natl Compr Canc Netw; 2018 Jan; 16(1):42-49. PubMed ID: 29295880
[No Abstract] [Full Text] [Related]
16. Midline involvement as a risk factor for vulvar cancer recurrence.
Stankevica J; Macuks R; Baidekalna I; Donina S
Asian Pac J Cancer Prev; 2012; 13(10):5237-40. PubMed ID: 23244142
[TBL] [Abstract][Full Text] [Related]
17. Association between obesity and vulvar cancer recurrence: an analysis of the AGO-CaRE-1 study.
Klapdor R; Hillemanns P; Wölber L; Jückstock J; Hilpert F; de Gregorio N; Hasenburg A; Sehouli J; Fürst S; Strauss H; Baumann K; Thiel F; Mustea A; Meier W; Harter P; Wimberger P; Hanker L; Schmalfeld B; Mahner S
Int J Gynecol Cancer; 2020 Jul; 30(7):920-926. PubMed ID: 32467335
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study.
McAlpine JN; Leung SCY; Cheng A; Miller D; Talhouk A; Gilks CB; Karnezis AN
Histopathology; 2017 Aug; 71(2):238-246. PubMed ID: 28257152
[TBL] [Abstract][Full Text] [Related]
19. Superficially invasive stage IA vulvar squamous cell carcinoma-therapy and prognosis.
Grimm D; Prieske K; Mathey S; Kuerti S; Burandt E; Schmalfeldt B; Woelber L
Int J Gynecol Cancer; 2019 Mar; 29(3):466-473. PubMed ID: 30622111
[TBL] [Abstract][Full Text] [Related]
20. Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study.
Woelber L; Griebel LF; Eulenburg C; Sehouli J; Jueckstock J; Hilpert F; de Gregorio N; Hasenburg A; Ignatov A; Hillemanns P; Fuerst S; Strauss HG; Baumann KH; Thiel FC; Mustea A; Meier W; Harter P; Wimberger P; Hanker LC; Schmalfeldt B; Canzler U; Fehm T; Luyten A; Hellriegel M; Kosse J; Heiss C; Hantschmann P; Mallmann P; Tanner B; Pfisterer J; Richter B; Neuser P; Mahner S
Eur J Cancer; 2016 Dec; 69():180-188. PubMed ID: 27837710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
